Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA).
Hecht JR, Lonardi S, Bendell J, Sim HW, Macarulla T, Lopez CD, Van Cutsem E, Muñoz Martin AJ, Park JO, Greil R, Wang H, Hozak RR, Gueorguieva I, Lin Y, Rao S, Ryoo BY. Hecht JR, et al. Among authors: munoz martin aj. J Clin Oncol. 2021 Apr 1;39(10):1108-1118. doi: 10.1200/JCO.20.02232. Epub 2021 Feb 8. J Clin Oncol. 2021. PMID: 33555926 Free PMC article. Clinical Trial.
Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group.
Garcia-Alfonso P, Muñoz-Martin A, Mendez-Ureña M, Quiben-Pereira R, Gonzalez-Flores E, Perez-Manga G. Garcia-Alfonso P, et al. Br J Cancer. 2009 Oct 6;101(7):1039-43. doi: 10.1038/sj.bjc.6605261. Epub 2009 Sep 8. Br J Cancer. 2009. PMID: 19738605 Free PMC article. Clinical Trial.
Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer.
García-Alfonso P, Muñoz-Martin AJ, Alvarez-Suarez S, Jerez-Gilarranz Y, Riesco-Martinez M, Khosravi P, Martin M. García-Alfonso P, et al. Among authors: martin m, munoz martin aj. Br J Cancer. 2010 Nov 9;103(10):1524-8. doi: 10.1038/sj.bjc.6605907. Epub 2010 Oct 26. Br J Cancer. 2010. PMID: 20978503 Free PMC article.
Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model.
Muñoz Martín AJ, García Alfonso P, Rupérez Blanco AB, Pérez Ramírez S, Blanco Codesido M, Martín Jiménez M. Muñoz Martín AJ, et al. Among authors: martin jimenez m. Clin Transl Oncol. 2014 Oct;16(10):927-30. doi: 10.1007/s12094-014-1165-y. Epub 2014 Mar 19. Clin Transl Oncol. 2014. PMID: 24643701
Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital.
Márquez-Rodas I, Lobo M, Flores-Sanchez C, Sanz M, Luque S, Lizarraga S, González-Asanza C, Pajares JA, Peligros MI, Bueno O, Mata C, Lopez C, López-Tarruella S, Jerez Y, Muñoz-Martin A, Blanco M, Die-Trill M, Justel JP, Solera J, Martin M. Márquez-Rodas I, et al. Oncology. 2017;92(2):68-74. doi: 10.1159/000452280. Epub 2016 Nov 18. Oncology. 2017. PMID: 27855387
Pancreatic ductal adenocarcinoma: metastatic disease.
Muñoz Martín AJ, Adeva J, Martínez-Galán J, Reina JJ, Hidalgo M. Muñoz Martín AJ, et al. Clin Transl Oncol. 2017 Dec;19(12):1423-1429. doi: 10.1007/s12094-017-1690-6. Epub 2017 Jun 16. Clin Transl Oncol. 2017. PMID: 28623515 Review.
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.
Macarulla T, Pazo-Cid R, Guillén-Ponce C, López R, Vera R, Reboredo M, Muñoz Martin A, Rivera F, Díaz Beveridge R, La Casta A, Martín Valadés J, Martínez-Galán J, Ales I, Sastre J, Perea S, Hidalgo M. Macarulla T, et al. J Clin Oncol. 2019 Jan 20;37(3):230-238. doi: 10.1200/JCO.18.00089. Epub 2018 Dec 4. J Clin Oncol. 2019. PMID: 30523758 Clinical Trial.
[Fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer].
Martínez Marín V, Muñoz Martín AJ, Viñuela Benéitez MC, García Alfonso P, Alonso Muñoz A, Pérez Manga G. Martínez Marín V, et al. Among authors: munoz martin aj. Med Clin (Barc). 2009 Sep 19;133(10):371-4. doi: 10.1016/j.medcli.2008.11.029. Epub 2009 Apr 1. Med Clin (Barc). 2009. PMID: 19339025 Spanish.
50 results